Director & Head of Clinical Pharmacology
Affimed GmbH
Paulien Ravenstijn is currently Director and Head of Clinical Pharmacology at Affimed GmbH which is a clinical-stage immuno-oncology company. Prior to her role at Affimed, Paulien has worked in the field of Clinical Pharmacology at Janssen R&D and qPharmetra where she gained over 15 years of experience throughout all stages of development in the areas of Neuroscience and Immuno-oncology. Paulien is an active member of ASCPT, serving in various leadership roles, currently being the chair for the TPM Network. Paulien has a MSc in BioPharmaceutical Sciences and a PhD in Pharmacology both from Leiden University in The Netherlands.
Disclosure information not submitted.
Monday, January 10, 2022
10:00 AM – 10:30 AM ET
Monday, January 10, 2022
11:30 AM – 12:30 PM ET
Tuesday, January 11, 2022
10:00 AM – 11:00 AM ET
Tuesday, January 11, 2022
11:15 AM – 12:15 PM ET
Wednesday, January 12, 2022
4:45 PM – 5:45 PM ET
Wednesday, March 16, 2022
12:00 PM – 1:00 PM ET
.png)